Tesla’nın Üretim Gecikmesi ve Harcama Çılgınlığı Piyasa Beklentilerini Sarsıyor

Tesla, Cybercab, Semi ve Megapack 3’ün 2026 yılına kadar “hacim üretim” hedefini geriye alarak, yatırımcıların gözlerini şirketin yeni nesil ürün harcamasına çevirdi.
Delayed Rollout of the Next‑Gen Trio
In the Q2 shareholder letter, the company removed the 2026 volume‑production promise for the three products and stripped the Optimus robot of its “volume production” language.
Q2 Financial Snapshot: Revenue vs Cash Flow
Tesla reported net income of $1.1 billion, down 5% YoY, while operating expenses jumped 47% to $4.3 billion. Free cash flow turned negative at $1 billion.
International Delivery Surge Fuels Growth
Deliveries jumped outside the United States, with record sales in South Korea, Australia, Colombia, Japan, Taiwan, Thailand, Portugal, the Philippines, Chile, Slovenia and Lithuania.
Capital Expenditure Ramp‑Up and Margin Pressure
Tesla plans $25 billion in capex for 2026—about three times its historical average—as it scales 4680 cell production and invests in new product lines.
Ege Kaan – Tesla’s production delays inject short‑term volatility into the stock, but the long‑term AI‑robotics pivot could reprice risk across the tech sector. Investors should monitor the $25 billion capex roadmap and the emerging negative cash‑flow trend, especially as the timeline for monetizing AI‑driven services remains uncertain.